Europe's Peroxfarma Brings its Expertise in Joint Care to America
BOCA RATON, Fla., Feb. 12, 2019 /PRNewswire/ -- Peroxfarma, a European pharmaceutical company and a pioneer in joint-care supplements, is bringing its Epaplus "Arthicare" supplements to the American consumer.
Millions of people living in America suffer from joint pain. Arthritis, one of the most common causes for joint pain, affects 21 percent of the adult population, and more than one-third of adults reported having joint pain in the past 30 days.
"Joint pain and arthritis are major health problems in the United States and throughout the world. It is affecting more and more young people, and it will be a major problem for aging baby boomers. We have years of experience developing nutritional supplements that address joint-pain ailments," said Joan Xiol Foret, the CEO of Peroxfarma, which is headquartered in Barcelona, Spain.
"We developed the Epaplus supplements to help people with joint-pain conditions," he said, adding that each supplement addresses different aspects and severity of joint pain. "Our supplements include Collagen, Magnesium, Vitamins, Hyaluronic acid and Silicon, all of which are needed to maintain healthy and flexible joints."
Peroxfarma, the company behind the Epaplus nutritional line, has years of experience as one of Europe's leading pharmaceutical companies and is known as an innovative leader in joint-care supplements. "Our goal from day one has been to improve people's lives," he said, adding that the company developed the Epaplus nutritional supplement line with the health needs of people in mind.
Peroxfarma's other nutritional supplements include Epaplus Sleepcare, Epaplus Skincare, Epaplus Vigorcare, Epaplus Immucare, Epaplus Digestcare, and Epaplus Vitalcare. All Peroxfarma supplements are sugar- and lactose-free with no dyes or preservatives.
"We created Epaplus supplements to provide an extra dose of health to people," Foret said. "Every day, we pursue new formulas and combinations of active ingredients to help people live their lives to their fullest potential."
For more information, check out Peroxfarma's website at peroxfarma.com/en.
Please direct inquiries to:
Andrew Polin, 561-544-0719
[email protected]
SOURCE Peroxfarma
Related Links
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article